A Phase I Dose Escalation Study Evaluating the Safety and Efficacy of TGR-1202 in patients with Relapsed or Refractory Hematologic Malignancies - Regional Cancer Care Associates LLC

Clinical Trials

A Phase I Dose Escalation Study Evaluating the Safety and Efficacy of TGR-1202 in patients with Relapsed or Refractory Hematologic Malignancies

Type of Cancer
Lung
Locations
Hackensack
Sponsor
SCRI
Protocol Number
TGR-1202-101
Cancer Diagnosis
To Learn More Call
201-510-0910